Work

Tables S2-S5 from Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer

Year: 2023

Type: other

Abstract: Supplementary Table S2. Sphere-initiating frequency in hypoxia as measured by LDA in vitro, related to Figure 1C. Supplementary Table S3. C-IC frequency following hypoxia as measured by LDA in vivo, related to Figure 1D. Supplementary Table S4. C-IC frequency following 5-FU + Evo as measured by LDA in vivo, related to Figure 5C. Supplementary Table S5. C-IC frequency following CRT + Evo as measured by LDA in vivo, related to Figure 5D.

DOI: 10.1158/1078-0432.22465221.v1

Authors: Jennifer Haynes, Trevor D. McKee, Andrew Haller, Yadong Wang, Cherry Leung, Deena M.A. Gendoo, Evelyne Lima-Fernandes, Antonija Kreso, Robin Wolman, Eva Szentgyorgyi, Douglass C. Vines, Benjamin Haibe-Kains, Bradly G. Wouters, Ur Metser, David A. Jaffray, Myles Smith, Catherine A. O'Brien

Language: English

Topic: Cancer Cells and Metastasis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361926309

Cites:

Cited by:

Related to: 10